High‐throughput microrna profiling of vitreoretinal lymphoma: Vitreous and serum microrna profiles distinct from uveitis

Abstract

Purpose: Vitreoretinal lymphoma (VRL) is a non‐Hodgkin lymphoma of the diffuse large B cell type (DLBCL), which is an aggressive cancer causing central nervous system related mortality. The pathogenesis of VRL is largely unknown. The role of microRNAs (miRNAs) has recently acquired remarkable importance in the pathogenesis of many diseases including cancers. Furthermore, miRNAs have shown promise as diagnostic and prognostic markers of cancers. In this study, we aimed to identify differentially expressed miRNAs and pathways in the vitreous and serum of patients with VRL and to investigate the pathogenesis of the disease. Materials and Methods: Vitreous and serum samples were obtained from 14 patients with VRL and from controls comprising 40 patients with uveitis, 12 with macular hole, 14 with epiretinal membrane, 12 healthy individuals. The expression levels of 2565 miRNAs in serum and vitreous samples were analyzed. Results: Expression of the miRNAs correlated significantly with the extracellular matrix (ECM) ‒ receptor interaction pathway in VRL. Analyses showed that miR‐326 was a key driver of B‐cell proliferation, and miR‐6513‐3p could discriminate VRL from uveitis. MiR‐1236‐3p correlated with vitreous interleukin (IL)‐10 concentrations. Machine learning analysis identified miR‐361‐3p expression as a discriminator between VRL and uveitis. Conclusions: Our findings demonstrate that aberrant microRNA expression in VRL may affect the expression of genes in a variety of cancerrelated pathways. The altered serum miRNAs may discriminate VRL from uveitis, and serum miR‐ 6513‐3p has the potential to serve as an auxiliary tool for the diagnosis of VRL.